- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 34.77M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 36.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 36.66M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $52.3M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $25.4M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $95.4M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $78.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $71.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $38.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $29.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $234.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $195.2M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $409.4M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $341.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.61B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.62B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $581.8M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $454.2M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.65B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.65B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.66 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.56 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.70 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.56 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $40.7M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $41.9M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $6.7M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $7M |
| Net Income | Q1 2026 · Mar 31, 2026 | $59.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | $20.5M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $116.4M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $111.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $141.6M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $136M |
| Revenue | Q1 2026 · Mar 31, 2026 | $258M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $247.9M |